Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

13 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Vital Signs and Physical Examination 12- Weeks Visits SirTac NCT02936388 - Vital Signs and Physical Examination 12- Weeks Visits

- 3/12/17 - 1 formulario, 2 itemgroups, 31 items, 1 idioma
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination 12- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination 3- Weeks Visits SirTac NCT02936388 - Vital Signs and Physical Examination 3- Weeks Visits

- 3/12/17 - 1 formulario, 2 itemgroups, 31 items, 1 idioma
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination 3- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination 6- Weeks Visits SirTac NCT02936388 - Vital Signs and Physical Examination 6- Weeks Visits

- 3/12/17 - 1 formulario, 2 itemgroups, 31 items, 1 idioma
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination 6- Weeks Visits. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination End of Therapy SirTac NCT02936388 - Vital Signs and Physical Examination End of Therapy

- 28/11/17 - 1 formulario, 2 itemgroups, 31 items, 1 idioma
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination End of Therapy. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Medical History Visit 08 SirTac NCT02936388 - Medical History Visit 08

- 26/11/17 - 1 formulario, 2 itemgroups, 11 items, 1 idioma
Itemgroups: Visit, quality of life
Study part: Medical History Visit 08. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Visit 06 SirTac NCT02936388 - Vital Signs and Physical Examination Visit 06

- 26/11/17 - 1 formulario, 2 itemgroups, 31 items, 1 idioma
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Visit 06. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Visit 07 SirTac NCT02936388 - Vital Signs and Physical Examination Visit 07

- 26/11/17 - 1 formulario, 2 itemgroups, 31 items, 1 idioma
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Visit 07. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Visit 03 SirTac NCT02936388 - Vital Signs and Physical Examination Visit 03

- 26/11/17 - 1 formulario, 2 itemgroups, 31 items, 1 idioma
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Visit 03. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Before every SIRT- or TACE- Treatment SirTac NCT02936388 - Vital Signs and Physical Examination Before every SIRT- or TACE- Treatment

- 26/11/17 - 1 formulario, 2 itemgroups, 31 items, 1 idioma
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Before every SIRT- or TACE- Treatment. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and Physical Examination Screening Day -14 to 0 SirTac NCT02936388 - Vital Signs and Physical Examination Screening Day -14 to 0

- 26/11/17 - 1 formulario, 2 itemgroups, 33 items, 1 idioma
Itemgroups: vital signs, Physical Examination
Study part: Vital Signs and Physical Examination Screening Day -14 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and ECOG Screening Day -7 to 0 SirTac NCT02936388 - Vital Signs and ECOG Screening Day -7 to 0

- 26/11/17 - 1 formulario, 2 itemgroups, 18 items, 1 idioma
Itemgroups: vital signs, quality of life
Study part: Vital Signs and ECOG Screening Day -7 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Vital Signs and ECOG Screening Day -7 to 0 SirTac NCT02936388 - Vital Signs and ECOG Screening Day -7 to 0

- 20/11/17 - 1 formulario, 2 itemgroups, 18 items, 1 idioma
Itemgroups: vital signs, quality of life
Study part: Vital Signs and ECOG Screening Day -7 to 0. A Randomized Phase II Trial of Transarterial Radioembolisation With Yttrium-90 (SIRT) in Comparison to Transarterial Chemoembolisation With Cisplatin (TACE) in Patients With Liver Metastases From Uveal Melanoma. Provided by Prof. Dr. Ulrich Keilholz, Charité – University of medicine Berlin. EudraCT-Nummer: 2014-002439-32. NCT02936388.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial